Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marla Diakow

Dermatology Brooklyn, NY Medical Doctor

NPI 1972940534 CMS profile 2784824

450 Clarkson Ave # 1262, Suny Downstate Medical Center, Brooklyn, NY 11203

Open in the dashboard

General payments

$12,839

604 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marla Diakow of Brooklyn, NY is reported in the CMS Open Payments database as having received $12,839 across 604 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,315 106
2024 General $1,775 85
2023 General $2,278 112
2022 General $1,724 72
2021 General $1,214 66
2020 General $884 47
2019 General $2,650 116

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marla Diakow
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Marla Diakow were reported at $2,315. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Marla Diakow Dermatology median Middle half National median
2019 $2,650 $454 $129–$1,240 $163
2020 $884 $235 $81–$756 $114
2021 $1,214 $377 $108–$1,108 $132
2022 $1,724 $514 $143–$1,391 $149
2023 $2,278 $607 $159–$1,674 $160
2024 $1,775 $751 $204–$1,903 $164
2025 $2,315 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,829 90 payments
  2. Pfizer Inc. $990 47 payments
  3. Novartis Pharmaceuticals Corporation $972 42 payments
  4. Incyte Corporation $948 31 payments
  5. Biofrontera Inc. $814 21 payments
  6. Janssen Biotech, Inc. $752 31 payments
  7. Galderma Laboratories, L.P. $654 47 payments
  8. Lilly USA, LLC $649 35 payments
  9. Amgen Inc. $595 28 payments
  10. Dermavant Sciences, Inc. $566 40 payments
  11. Other $4,069 192 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $11,974 600 payments
  2. Honoraria $350 1 payment
  3. Consulting Fee $350 1 payment
  4. Education $165 2 payments
Products named General payments · program years 2019–2025
  1. SKYRIZI $1,122 50 payments
  2. OPZELURA $948 31 payments
  3. EUCRISA $784 38 payments
  4. XEPI $653 12 payments
  5. TREMFYA $634 25 payments
  6. Ameluz $630 11 payments
  7. BF-RhodoLED $630 11 payments
  8. COSENTYX $614 31 payments
  9. VTAMA $610 42 payments
  10. Otezla $595 28 payments
  11. Other $9,227 431 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

612

Median for Dermatology: 534

Drug cost

$106,464

Median for Dermatology: $67,151

Branded share of claims

10.5%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Taltz Autoinjector Ixekizumab Brand 14 $91,900
Clobetasol Propionate Generic 63 $3,733
Ketoconazole Generic 139 $3,085
Tacrolimus Generic 13 $1,541
Triamcinolone Acetonide Generic 99 $1,238
Metronidazole Generic 23 $1,098
Tretinoin Generic 13 $1,037
Clindamycin Phosphate Generic 16 $644
Ciclopirox Ciclopirox Olamine Brand 24 $596
Hydrocortisone Generic 105 $547

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$149,071

Of which drugs: $4,032

Medicare patients

580

Average age 75

Services billed

6,316

403 women, 177 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 47%
Ischemic heart disease 25%
Diabetes 23%
Osteoporosis 23%
Cancer 19%
Depression 17%
Chronic kidney disease 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg J7345 Office 12 3,000 $4,005
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 25 39 $27

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VTAMA
  • Dermavant Sciences, Inc. $318
$318 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $272
$272 — —
OPZELURA
  • Incyte Corporation $253
$253 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $214
$214 — —
SKYRIZI
  • AbbVie, Inc. $180
$180 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

604 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record